Skip to main content
Clinical Trials/NL-OMON37385
NL-OMON37385
Completed
Not Applicable

The role of humoral autoimmunity in the aetiology of achalasia. - Antibodies in achalasia.

Academisch Medisch Centrum0 sites400 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Achalasia
Sponsor
Academisch Medisch Centrum
Enrollment
400
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with achalasia:
  • \- Diagnosis of achalasia confirmed by:
  • \- Oesophageal manometry; aperistalsis, LOS dysrelaxation and hypertensive LOS (\>10mmHg).
  • \- Barium oesophagogram; delayed emptying, aperistalsis and dilatation of the oesophagus with narrowing of the distal oesophagus.
  • \- Eckhardt score \* 2\.
  • \- Age 18\-75 years.
  • \- Written informed consent;Healthy controls:
  • \- Age 18\-75 years.
  • \- Written informed consent

Exclusion Criteria

  • Patients with achalasia:
  • \- Pseudoachalasia
  • \- Chagas disease
  • \- Upper gastrointestinal malignancy;Healthy controls:
  • \- Symptoms suggestive of oesophageal disease.
  • \- History of malignancy.
  • \- History of diseases affecting the upper gastrointestinal tract (gastro\-oesophageal reflux disease, eosinophilic oesophagitis)
  • \- Pseudoachalasia
  • \- Chagas disease
  • \- Autoimmune diseases

Outcomes

Primary Outcomes

Not specified

Similar Trials